Life-extension therapy: MiRNA-1827 inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 15/December/2016, 10.57 pm

Natural product-derived therapy for Human Leukemias: Kukoamine A (KuA), a spermine alkaloid derived from Cortex lycii radicis and Lycium chinense among others, suppresses B-Cell and myeloid leukemias via up regulation of the tumor suppressor IRF4, 15/December/2016, 10.53 pm
December 15, 2016
Natural product-derived antiviral therapy against chikungunya (CHIKV) and Zika (ZIKV) viruses. Naringenin, a flavone found in grapefruit, decreases spermidine/spermine N1-acetyltransferase (SAT) expression, depletes spermidine and Spermine levels, and restricts Chikungunya and Zika viruses replication via up regulation of its target gene, 15/December/2015, 11.04 pm
December 15, 2016
Show all

What they say?

A recent study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published in the 2 October 2009 issue of the Journal “Science” (I.F: 31.477 ) by Prof Dominic J. Withers, Dr. Selman C and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMDreports, for the first time, that: Life-extension therapy: MiRNA-1827 inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span


Research findings to Therapeutic opportunity: 

This study suggests an miRNA-based life extension therapy. MiR-1827, by  decreasing  the expression of its target gene, it may suppress Ribosomal protein S6 kinase 1 (p70S6 Kinase) expression. Thereby, it may promote: (1) resistance to bone, immune, and motor dysfunction; (2) insulin sensitivity; and (3) longevity (figs. 1 and 2).   

price-100[easy_payment currency=”USD”]

Thus, pharmacological formulations encompassing “MiRNA-1827 or its activators or MiRNA-1827 in combination with any of the known longevity-promoting compound(s) can be used to extend the lifespan of an individual (fig. 2).


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed Information: How MiR-1827 decreases the expression of p70 S6 Kinase and promotes mammalian life span?

# Research cooperation

Amount: $100 #


References:

CitationBoominathan, L.,  Life-extension therapy: MiRNA-1827 inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 15/December/2016, 10.57 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.